ZA878812B - 3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof - Google Patents

3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof

Info

Publication number
ZA878812B
ZA878812B ZA878812A ZA878812A ZA878812B ZA 878812 B ZA878812 B ZA 878812B ZA 878812 A ZA878812 A ZA 878812A ZA 878812 A ZA878812 A ZA 878812A ZA 878812 B ZA878812 B ZA 878812B
Authority
ZA
South Africa
Prior art keywords
pyrroles
alkanoyl
omega
hydroxyphenyl
butyl
Prior art date
Application number
ZA878812A
Other languages
English (en)
Inventor
Joseph M Muchowski
M Muchowski Joseph
Robert J Greenhouse
J Greenhouse Robert
John M Young
M Young John
D V Krishna Murthy
V Krishna Murthy D
Brian H Vickery
H Vickery Brian
Keith A M Walker
A M Walker Keith
Ruei-Chen Chin
Chin Ruei-Chen
Anthony Prince
Prince Anthony
Moysey M Povzhitkov
M Povzhitkov Moysey
John O Gardner
O Gardner John
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA878812B publication Critical patent/ZA878812B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA878812A 1986-11-25 1987-11-24 3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof ZA878812B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/936,551 US4833155A (en) 1986-11-25 1986-11-25 3-(ω-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and anti-inflammatory uses thereof

Publications (1)

Publication Number Publication Date
ZA878812B true ZA878812B (en) 1989-06-28

Family

ID=25468795

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA878812A ZA878812B (en) 1986-11-25 1987-11-24 3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof

Country Status (13)

Country Link
US (1) US4833155A (da)
EP (1) EP0269981A1 (da)
JP (1) JPS63154658A (da)
KR (1) KR880006191A (da)
AU (1) AU8164287A (da)
DK (1) DK617487A (da)
FI (1) FI875184A (da)
HU (2) HUT46303A (da)
IL (1) IL84577A0 (da)
NO (1) NO874892L (da)
PH (1) PH24245A (da)
PT (1) PT86205B (da)
ZA (1) ZA878812B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086064A (en) * 1990-03-27 1992-02-04 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxyphenyl thiazolyl, oxazolyl, and imidazolyl methanones and related compounds as antiinflammatory agents
US5234939A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxyphenyl imidazolyl methanones and related compounds as antiinflammatory agents
US5234937A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents
US5102897A (en) * 1990-03-27 1992-04-07 Warner-Lambert Company 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues
FR2669029B1 (fr) * 1990-11-14 1994-09-02 Adir Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5684204A (en) * 1995-11-15 1997-11-04 The Procter & Gamble Company Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
ES2230624T5 (es) * 1996-11-27 2010-10-25 Aventis Pharmaceuticals Inc. Composicion farmaceutica que comprende un compuesto que tiene actividad anti-xa y un compuesto antagonista de la agregacion plaquetaria.
WO2004064781A2 (en) * 2003-01-14 2004-08-05 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
AU2007311084A1 (en) 2006-10-17 2008-04-24 Albemarle Corporation Alkylated heterocyclic reaction products useful as antioxidants
FR2934998B1 (fr) * 2008-08-12 2010-09-03 Robert Vachy Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644631A (en) * 1969-05-13 1972-02-22 Endo Lab Therapeutic methods utilizing aryl pyrrol-3-yl ketones
US4000160A (en) * 1973-04-11 1976-12-28 Sterling Drug Inc. Pyrrolyl oxyphenyl ketones
US4124725A (en) * 1977-05-16 1978-11-07 Riker Laboratories, Inc. Anti-inflammatory method
US4418074A (en) * 1981-11-23 1983-11-29 Riker Laboratories, Inc. 2,6 Di(t-butyl)-4-(2'-pyrrol)-phenol and anti-inflammatory use thereof

Also Published As

Publication number Publication date
PH24245A (en) 1990-05-04
US4833155A (en) 1989-05-23
HUT47904A (en) 1989-04-28
NO874892L (no) 1988-06-17
AU8164287A (en) 1988-05-26
PT86205A (en) 1987-12-01
HUT46303A (en) 1988-10-28
FI875184A0 (fi) 1987-11-24
DK617487D0 (da) 1987-11-24
KR880006191A (ko) 1988-07-22
EP0269981A1 (en) 1988-06-08
NO874892D0 (no) 1987-11-24
PT86205B (pt) 1990-11-07
JPS63154658A (ja) 1988-06-27
DK617487A (da) 1988-05-26
HU201010B (en) 1990-09-28
FI875184A (fi) 1988-05-26
IL84577A0 (en) 1988-04-29

Similar Documents

Publication Publication Date Title
GB8811591D0 (en) Personal medication apparatus
IL88670A0 (en) 2,5-diaryl-tetrahydrofurans and analogs thereof and pharmaceutical compositions containing them
DE3565468D1 (en) Drug administering apparatus
OA09736A (en) "Human interleukin-3 and muteins thereof".
PT85468A (en) Pharmaceutical formulations
ZA878812B (en) 3-(omega(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles their deoxy analogs,and therapeutic uses thereof
GB8624227D0 (en) Electrotherapeutic apparatus
NZ221189A (en) 1,4-benzodiazepines and pharmaceutical compositions
GB2193642B (en) Gas administration apparatus
IL91356A0 (en) Therapeutic nucleosides,their preparation and pharmaceutical compositions containing them
GB8804531D0 (en) Skin treatment formulations
ZA887364B (en) Ovulation treatment
GB8626188D0 (en) Medical apparatus
GR871915B (en) Pharmaceutical formulations
GB8804917D0 (en) Medical apparatus
BG43202A1 (en) Solid oral therapeutic form containing silimarin
GB8902424D0 (en) Medicinal formulations
ZA885979B (en) Skin treatment composition biospecific polymers
RU1833744C (en) Device for individual taking of v,n,pozdnyakov's medicinal means
IL106709A0 (en) Therapeutic uses of 2',5'-oligoadenylates
GB8627282D0 (en) Surgical diathermy apparatus
GB8623293D0 (en) Surgical diathermy apparatus
ZA873848B (en) Therapeutic apparatus
GB8626997D0 (en) Therapeutic device
IE891758L (en) Therapeutic uses of 2', 5'-oligoadenylates